Banana Boat Hair & Scalp Sunscreen Spray SPF 30 recalled
Edgewell Personal Care Company issued a voluntary national recall of 3 collections of Banana Boat Hair & Scalp Sunscreen due to the presence of benzene.
FDA approves ustekinumab to treat pediatric psoriatic arthritis
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
Roflumilast cream 0.3% for plaque psoriasis approved by FDA
Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.
Safety, efficacy of berdazimer gel for molluscum contagiosum
Stephen Stripling, MD, FAAP, discusses results published in JAMA Dermatology about the efficacy and safety of berdazimer gel 10.3% for the treatment of molluscum contagiosum.
FDA approves ruxolitinib cream 1.5% to treat nonsegmental vitiligo
Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.
How dupilumab improves AD in pediatric, adult patients
Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the 2022 Maui Dermatology Conference for PAs & NPs.
FDA issues third CRL in 2 years to Verrica Pharmaceuticals
Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.
Pediatric dermatology update: 2022’s top studies
James Treat, MD, dives into pediatric patients dealing with alopecia areata, sleep issues in children with atopic dermatitis, and more.
2 Commerce Drive Cranbury, NJ 08512